Knowledge hub
Peptide Science. Research. Discovery.
Evidence-focused insights into peptide science, emerging compounds, clinical research and the future of peptide medicine. Sixteen research hubs, each mapping a topic from first principles down to individual compounds, comparisons and safety limits.
Research hubs
Start with the hub that matches what you are researching. Each one states its evidence position up front — from established clinical evidence through to early laboratory work.
Peptide Science
How peptides are built, how they signal, how they are synthesised and how they are studied — the foundational science behind every other topic on this site.
Established clinical evidence
Weight Loss & Metabolic Peptides
Incretin and amylin pharmacology explained: GLP-1, GIP, glucagon and multi-receptor agonists, what the trials measured, and where the evidence stops.
Established clinical evidence
Regenerative Peptides
BPC-157, TB-500, GHK-Cu and related sequences studied in tendon, ligament, muscle and wound-healing models — mechanisms, evidence tiers and honest limitations.
Mostly preclinical
Longevity & Anti-Aging
The measurable biology of ageing — telomere dynamics, senescence, mitochondrial decline — and the peptides studied against those endpoints, with evidence tiers.
Early laboratory research
Muscle, Recovery & Performance Research
What research says about peptides studied in muscle protein synthesis, connective-tissue recovery and exercise physiology — and why most of it is preclinical.
Mostly preclinical
Skin, Hair & Aesthetic Peptides
Copper peptides, signal peptides and carrier peptides in dermatological research — collagen synthesis, wound healing and hair-follicle studies, with evidence limits.
Emerging human research
Cognitive & Neuroactive Peptides
Semax, Selank and related neuroactive peptides — BDNF signalling, blood-brain barrier constraints, and why most of the evidence base is regionally limited.
Early laboratory research
Growth Hormone & Secretagogue Peptides
GHRH analogues and ghrelin-receptor secretagogues explained — pulsatility, IGF-1 mediation, comparative pharmacology and regulatory status.
Emerging human research
Immune & Antimicrobial Peptides
Thymosin Alpha-1, LL-37 and the antimicrobial peptide field — innate immunity mechanisms, resistance research and the state of clinical evidence.
Emerging human research
Mitochondrial Peptides
Mitochondrial-derived peptides and mitochondria-targeting compounds — cardiolipin binding, metabolic signalling and the current clinical trial picture.
Emerging human research
Peptide Research & Clinical Trials
How peptide research is conducted and graded — trial phases, endpoints, evidence hierarchy, and how to read a peptide study without over-reading it.
Established clinical evidence
Peptide Safety
What is actually known about peptide safety — immunogenicity, contamination, unknown long-term profiles, and why absence of reported harm is not evidence of safety.
Emerging human research
Peptide Regulation
How peptides are regulated worldwide — approved medicines versus research chemicals, FDA and EMA frameworks, compounding rules and anti-doping status.
Established clinical evidence
Peptide Comparisons
Head-to-head peptide comparisons built on evidence tables — mechanism, pharmacology, study base and limitations, without unsupported superiority claims.
Emerging human research
Latest Peptide Research
Where peptide science is moving now — multi-receptor metabolic agonists, oral delivery, mitochondrial signalling and AI-assisted peptide design.
Emerging human research
Peptide Glossary
Plain-English definitions of the terms used across peptide research — agonist, half-life, bioavailability, in vitro, secretagogue, endotoxin and more.
Established clinical evidence
How this library is built
Evidence tiers, always labelled
Human, animal and laboratory findings are never blended. Where controlled human data does not exist, we say so on the page.
Entities, not keywords
Every hub names the compounds, receptors and mechanisms inside it, so a search for a compound, a mechanism or a whole category all lead somewhere useful. 457 tracked topics and counting.
No commercial content
This is an independent publication. Nothing is sold here; suppliers are referenced separately and marked as such.